Annual report pursuant to Section 13 and 15(d)

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

v3.24.1
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
 12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

NOTE 8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

The Company’s accounts payable and accrued liabilities consist of the following:

 

    December 31, 2023     December 31, 2022  
Trade payables   £ 1,847,279     £ 882,364  
Other tax and social security     139,029       293,467  
Accruals     1,229,419       944,904  
Amounts accrued in respect to clinical trial testing     1,177,500       -  
Other payables     38,613       38,323  
Total   £ 4,431,840     £ 2,159,058  

 

The fair value of accounts payable and accrued expenses are not materially different to the book value.